FDA Approves AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE — Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. received FDA approval for the alternative ANDA 091431 to market Amlodipine and Benazepril Hydrochloride tablets, enhancing generic competition in the hypertension and heart failure market. The approval is expected to increase breakthrough therapy options for patients and dynamic pricing pressures on brand-name offerings.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed